Global Opioid Induced Constipation Drugs Market Research Report 2021
Global Opioid Induced Constipation Drugs Market Research Report 2021
Opioid Induced Constipation Drugs Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Opioid Induced Constipation Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Opioid Induced Constipation Drugs Market Overview:
Global Opioid Induced Constipation Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Opioid Induced Constipation Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Opioid Induced Constipation Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Opioid Induced Constipation Drugs market in 2020.
Global Opioid Induced Constipation Drugs Market Segmentation
By Type, Opioid Induced Constipation Drugs market has been segmented into:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
By Application, Opioid Induced Constipation Drugs market has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Opioid Induced Constipation Drugs market are:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co. Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co. Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1. Market Overview of Opioid Induced Constipation Drugs
1.1 Opioid Induced Constipation Drugs Market Overview
1.1.1 Opioid Induced Constipation Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Opioid Induced Constipation Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Opioid Induced Constipation Drugs Historic Market Size by Regions (2015-2020)
1.4 Opioid Induced Constipation Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Opioid Induced Constipation Drugs Sales Market by Type (2015-2026)
2.1 Global Opioid Induced Constipation Drugs Historic Market Size by Type (2015-2020)
2.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Type (2021-2026)
2.3 Lubiprostone
2.4 Methyl Naltrexone Bromide
2.5 Naldemedine
2.6 Alvimopan
2.7 Others
3. Covid-19 Impact Opioid Induced Constipation Drugs Sales Market by Application (2015-2026)
3.1 Global Opioid Induced Constipation Drugs Historic Market Size by Application (2015-2020)
3.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Application (2021-2026)
3.3 Hospital Pharmacies
3.4 Retail Pharmacies
3.5 Online Pharmacies
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Opioid Induced Constipation Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Opioid Induced Constipation Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Opioid Induced Constipation Drugs Business
5.1 Ironwood Pharmaceuticals Inc
5.1.1 Ironwood Pharmaceuticals Inc Company Profile
5.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Specification
5.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Daiichi Sankyo Co Ltd
5.2.1 Daiichi Sankyo Co Ltd Company Profile
5.2.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Specification
5.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Pfizer
5.3.1 Pfizer Company Profile
5.3.2 Pfizer Opioid Induced Constipation Drugs Product Specification
5.3.3 Pfizer Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Progenics Pharmaceuticals Inc
5.4.1 Progenics Pharmaceuticals Inc Company Profile
5.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Specification
5.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Shionogi & Co. Ltd
5.5.1 Shionogi & Co. Ltd Company Profile
5.5.2 Shionogi & Co. Ltd Opioid Induced Constipation Drugs Product Specification
5.5.3 Shionogi & Co. Ltd Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Allergan Plc
5.6.1 Allergan Plc Company Profile
5.6.2 Allergan Plc Opioid Induced Constipation Drugs Product Specification
5.6.3 Allergan Plc Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Nektar Therapeutics
5.7.1 Nektar Therapeutics Company Profile
5.7.2 Nektar Therapeutics Opioid Induced Constipation Drugs Product Specification
5.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Purdue Pharma
5.8.1 Purdue Pharma Company Profile
5.8.2 Purdue Pharma Opioid Induced Constipation Drugs Product Specification
5.8.3 Purdue Pharma Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 S.L.A. Pharma AG
5.9.1 S.L.A. Pharma AG Company Profile
5.9.2 S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Specification
5.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Mundipharma International Limited
5.10.1 Mundipharma International Limited Company Profile
5.10.2 Mundipharma International Limited Opioid Induced Constipation Drugs Product Specification
5.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Ono Pharmaceutical Co. Ltd
5.11.1 Ono Pharmaceutical Co. Ltd Company Profile
5.11.2 Ono Pharmaceutical Co. Ltd Opioid Induced Constipation Drugs Product Specification
5.11.3 Ono Pharmaceutical Co. Ltd Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Takeda Pharmaceutical Company Limited
5.12.1 Takeda Pharmaceutical Company Limited Company Profile
5.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Specification
5.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Theravance Biopharma Inc
5.13.1 Theravance Biopharma Inc Company Profile
5.13.2 Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Specification
5.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Valeant Pharmaceuticals International
5.14.1 Valeant Pharmaceuticals International Company Profile
5.14.2 Valeant Pharmaceuticals International Opioid Induced Constipation Drugs Product Specification
5.14.3 Valeant Pharmaceuticals International Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Cosmo Pharmaceuticals SA
5.15.1 Cosmo Pharmaceuticals SA Company Profile
5.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Specification
5.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Daewoong Pharmaceutical
5.16.1 Daewoong Pharmaceutical Company Profile
5.16.2 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Specification
5.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 C.B. Fleet Company
5.17.1 C.B. Fleet Company Company Profile
5.17.2 C.B. Fleet Company Opioid Induced Constipation Drugs Product Specification
5.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Sucampo Pharmaceuticals
5.18.1 Sucampo Pharmaceuticals Company Profile
5.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Specification
5.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Opioid Induced Constipation Drugs Market Size (2015-2026)
6.2 North America Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
6.3 North America Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
6.4 North America Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Opioid Induced Constipation Drugs Market Size (2015-2026)
7.2 East Asia Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
7.3 East Asia Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
7.4 East Asia Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Opioid Induced Constipation Drugs Market Size (2015-2026)
8.2 Europe Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
8.3 Europe Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
8.4 Europe Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Opioid Induced Constipation Drugs Market Size (2015-2026)
9.2 South Asia Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
9.3 South Asia Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
9.4 South Asia Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Opioid Induced Constipation Drugs Market Size (2015-2026)
10.2 Southeast Asia Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Opioid Induced Constipation Drugs Market Size (2015-2026)
11.2 Middle East Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
11.3 Middle East Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
11.4 Middle East Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Opioid Induced Constipation Drugs Market Size (2015-2026)
12.2 Africa Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
12.3 Africa Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
12.4 Africa Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Opioid Induced Constipation Drugs Market Size (2015-2026)
13.2 Oceania Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
13.3 Oceania Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
13.4 Oceania Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Opioid Induced Constipation Drugs Market Size (2015-2026)
14.2 South America Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
14.3 South America Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
14.4 South America Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Opioid Induced Constipation Drugs Market Size (2015-2026)
15.2 Rest of the World Opioid Induced Constipation Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
16 Opioid Induced Constipation Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Opioid Induced Constipation Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|